Guide to Hormone Optimization: Your Health Matters

A Comprehensive Guide to Hormone Optimization: Debunking Myths and Unveiling the Science of Lifelong Wellness

Abstract

Welcome to a comprehensive exploration of hormone optimization. As a practitioner dedicated to integrative and functional medicine, holding credentials in chiropractic (DC), advanced practice nursing (APRN, FNP-BC), and functional medicine (CFMP, IFMCP), I am here to guide you through the latest evidence-based research on hormonal health. This educational post will dismantle long-standing myths surrounding hormone replacement therapy, particularly concerning estrogen, progesterone, and testosterone. We will journey through the flawed conclusions of the Women’s Health Initiative (WHI), differentiate between bioidentical hormones and risky synthetic progestins, and explore the true, synergistic roles these critical molecules play in our health—from cardioprotection and bone density to cancer prevention and cognitive function. We’ll examine the profound connection between hormone levels and chronic pain, mood, and vitality in individuals. By dissecting the evidence and understanding the underlying physiological mechanisms, we can appreciate how a properly managed, integrative approach—including foundational chiropractic care—can optimize hormonal health, prevent chronic disease, and significantly improve quality of life. This is about moving beyond fear and embracing an evidence-based path to wellness.

Questioning “Standard” Medical Narratives: The Case for Hormones

Hello, I’m Dr. Jimenez. I’m excited to share some powerful insights with you today, drawing from my clinical experience and the groundbreaking work of leading researchers. In my years of clinical practice, I’ve learned that the most important question we can ask is, “Why?” Many of you are exploring integrative health because the conventional answers aren’t working. You sense there has to be a better way. This inquisitive spirit is essential, especially when we examine the history of hormone replacement therapy (HRT).

For too long, medical training has relied on the mantra, “That’s the way we’ve always done it.” This is an unacceptable answer. It stifles progress and, in the case of hormones, has caused immense harm. The term “hormone” itself comes from an ancient Greek word meaning “to set in motion.” Isn’t that a perfect description? These molecules are made in one part of the body, travel to another, and lock into specific receptors on cells, triggering a cascade of essential actions. If a cell has a receptor for a hormone, it’s there for a reason—it’s expecting a signal. Problems don’t arise because our cells have receptors; they arise from how those hormonal signals are managed and balanced.

Our bodies don’t create toxic chemicals on purpose. So, if hormones like estrogen, progesterone, and testosterone are naturally produced, why have they been so vilified? The answer lies not in the hormones themselves, but in the flawed science that misrepresented them.

The Women’s Health Initiative: A Study Built on a Faulty Foundation

Let’s start by dissecting the infamous Women’s Health Initiative (WHI) study from 2002. This study single-handedly created a tidal wave of fear that persists to this day. But what if the study had used the right molecules and the right delivery systems from the start?

The WHI used two key products:

• Premarin: Conjugated equine estrogens derived from pregnant mare’s urine. This is not human estrogen.
• Provera (medroxyprogesterone acetate): A synthetic progestin, not the natural progesterone our bodies produce.

Both were administered orally. This detail is critically important. When you take a hormone orally, it first passes through the portal circulation to the liver. This “first-pass metabolism” places a significant burden on the liver, which responds by producing inflammatory byproducts, including clotting factors. This is why oral estrogens, whether in birth control pills or Premarin, are known to increase the risk of blood clots. This increase in clotting risk effectively negated the well-established cardioprotective benefits of estrogen.

Had the WHI used 17-beta estradiol (the primary, bioidentical estrogen our bodies produce) and a non-oral delivery system (like a patch or cream), the increased clotting factors, strokes, and heart attacks would have been eliminated. Furthermore, the study used medroxyprogesterone acetate (a progestin), whose molecular structure differs significantly from that of natural progesterone. Has natural, bioidentical progesterone ever been shown to increase breast cancer risk? No, not once.

If the correct molecules and delivery systems had been used, the WHI’s conclusion would have been radically different. Medical organizations today would be recommending that every menopausal woman start and continue estrogen and progesterone for life.

The Aftermath and the Reversal: What the Follow-Up Data Really Shows

In my practice in 2002, when the WHI results hit the front page of Time magazine, the fallout was immediate. Panic ensued. I had to hire extra staff just to field the flood of calls from terrified patients wanting to stop their hormones. It’s estimated that half of the women on HRT in the U.S. stopped their treatment. Think about the consequences. How many of those women went on to develop Alzheimer’s disease, osteoporosis, or heart disease?

But the media rarely reports the follow-up.

• The Re-analysis (2013): Over a decade later, a re-analysis of the WHI data revealed that in the estrogen-only arm of the study (women who had a hysterectomy and took Premarin without Provera), there was actually a trend toward breast cancer prevention.
• The Long-Term Follow-Up (2020): An even longer-term follow-up study looked at the same group of women nearly 18 years later. The findings were stunning. The women who had taken estrogen for about eight years had a lower incidence of breast cancer and were less likely to die from breast cancer over the course of their lives (Chlebowski et al., 2020).

Let that sink in. The only medicine in the history of the world shown in a prospective, randomized, placebo-controlled trial to reduce both the risk of getting and dying from breast cancer is estrogen. And this was demonstrated using Premarin, an imperfect form of estrogen. This information, published years ago, should have revolutionized oncology and women’s health.

The Power of Progesterone: Calming, Protective, and Misunderstood

Progesterone is another profoundly misunderstood hormone. It is crucial throughout a woman’s life, and its role is often confused with that of synthetic progestins.

• Progestins are NOT Progesterone: Molecules like medroxyprogesterone acetate (Provera) are synthetic compounds that do not share progesterone’s molecular structure or full range of biological benefits.
• Synergy, Not Opposition: The idea that progesterone simply “opposes” estrogen is an oversimplification. They work synergistically as a team. Estrogen builds the uterine lining (the endometrium), and progesterone stabilizes and matures it.

The misconception that progesterone is only necessary for women with a uterus to prevent uterine cancer is dangerously outdated. What about the progesterone receptors in the brain, heart, and bones? Are they supposed to remain empty just because a woman has had a hysterectomy? To ignore these systemic needs is physiologically unsound.

A critical clinical pearl is about delivery. Progesterone is a very large molecule; it does not absorb well through the skin to achieve systemic blood levels adequate for uterine protection. To protect the uterine lining from estrogen’s growth effects, you must use a delivery method like oral, sublingual, or vaginal forms. I have seen the tragic consequences of this mistake—patients developing endometrial hyperplasia or cancer because they were on estrogen with only a progesterone cream for “balance.”

Testosterone: A Critical Human Hormone, Not Just for Men

One of the biggest myths in medicine that I have been working to dismantle for over 15 years is the notion that testosterone is exclusively a male hormone. The science is unequivocal: testosterone is a critical human hormone.

• A woman will produce more testosterone over her lifetime than she will estrogen.
• The androgen receptor is located on the X chromosome. This evidence proves the hormone is fundamental to female biology.

Taking out a woman’s ovaries (oophorectomy) removes the primary source of her testosterone, estrogen, and progesterone. Nevertheless, the conventional approach is often to replace only one estrogen while completely ignoring the others. This leaves thousands of receptors for testosterone and progesterone empty, depriving the body of their protective and vital functions.

The symptoms of hormonal deficiency are remarkably similar in individuals because the receptors are in the same places. Fatigue, brain fog, depression, anxiety, loss of libido, muscle weakness, and bone loss are human problems, not gender-specific ones.

Debunking the Great Testosterone and Prostate Cancer Myth

For decades, a pervasive fear has shadowed men’s health: the idea that testosterone therapy is “like adding fuel to the fire” of prostate cancer. To debunk this myth, we must look to the incredible work of Dr. Abraham Morgentaler, a professor at Harvard Medical School. His research traced this myth back to a 1940s study of just two men with end-stage, metastatic prostate cancer. A conclusion from such a profoundly flawed study dictated medical practice for over 70 years.

Dr. Morgentaler’s evidence-based research revealed the truth:

• Men with naturally high testosterone do not have a higher incidence of prostate cancer.
• Low testosterone is actually an independent risk factor for developing more aggressive prostate cancer.
• For men who have been treated for prostate cancer, testosterone therapy can and should be initiated to restore quality of life as soon as they show no evidence of recurrence.

The Prostate Saturation Model: Why Optimization is Safe

One of the most common reasons I see patients being denied therapy is a concern over BPH (Benign Prostatic Hyperplasia). This is where understanding the Prostate Saturation Model is critical. Dr. Morgentaler’s research found that the androgen receptors in prostate cells become fully saturated at a total testosterone level of around 200-250 ng/dL.

The clinical implication is profound. Most men I see present with levels around 350 ng/dL and already have BPH symptoms. If his prostate’s androgen receptors are already fully saturated, how can I make his BPH worse by taking his testosterone level from 350 ng/dL to an optimal level of 950 ng/dL? The prostate isn’t “seeing” any more testosterone. Therefore, if a man’s PSA does rise significantly after starting therapy, it’s not the testosterone causing the problem; it’s unmasking an underlying pathology that was already there.

The Brain on Hormones: Preventing Cognitive Decline and Enhancing Mood

While much of the debate has centered on the prostate and breast, the effects of hormones on the brain are arguably even more critical for long-term health. It is far easier to prevent a problem than to reverse it.

A landmark study in JAMA Neurology followed over 160,000 male veterans and found that men in the lowest quintile for testosterone had an 80% higher risk of dementia compared to men in the highest quintile (Kim et al., 2021). This is the crux of why we must move beyond “normal” and strive for “optimal.”

In my practice, we see profound transformations in mental wellness. A review of 187 of our new telehealth patients who started on personalized hormone optimization showed that after six months, 87% reported a significant decrease in depression. This outcome far surpasses the typical results seen with standard antidepressant medications, and it does so without the lengthy list of side effects. We are not masking symptoms; we are restoring the body’s innate ability to regulate itself.

Optimal vs. Normal: Redefining Our Therapeutic Goals

We must stop using the word “normal.” A lab reference range for testosterone, say 300 to 1100 ng/dL, is a statistical reference range, not a measure of health. It simply represents a bell curve of the population tested. It does not tell you where an individual feels or functions best.

A man with a testosterone level of 325 ng/dL is told he is “normal.” But the data shows he may have an 80% higher risk for dementia than a man with a level of 900 ng/dL, who is also “normal.” In my clinical opinion, there is no such thing as “low normal” or “high normal.” There is only suboptimal and optimal. Our goal with hormone optimization is to move patients from the suboptimal part of the range to the optimal part—typically the upper quartile for a healthy young adult. We are restoring the level at which their body was designed to function best.

A Modern Protocol for Strong Bones and Pain-Free Joints

Another area where conventional medicine falls short is in treating osteoporosis. The standard approach often involves bisphosphonates, drugs that inhibit osteoclasts (the cells that break down old bone). This halts the vital process of bone remodeling. You are left with a skeleton composed of old, brittle bone that may be denser but is not stronger.

My approach is about supporting the body’s natural processes. A cornerstone is optimizing hormones. Estrogen supports bone formation and regulates bone resorption. Testosterone is also powerfully anabolic to bone. The evidence is compelling: a study found that women using testosterone pellets experienced an average increase in bone density of 8.3% per year (Amor, 2005), far exceeding the effects of bisphosphonates.

This hormonal link is also critical for joint pain. For all individuals, the conversion of testosterone to estrogen is crucial for joint health. The most common symptom of menopause isn’t hot flashes; it’s pain—joint pain, bone pain, and muscle pain. I’ll never forget the first patient whose fibromyalgia vanished after starting hormone therapy. It’s a common story in my clinic, demonstrating the profound anti-inflammatory and protective effects of optimized hormones.

Demystifying Testosterone and Cardiovascular Health

Perhaps the greatest area of misinformation lies in the relationship between testosterone and heart health. The fear largely stems from a deeply flawed 2013 VA study published in JAMA, which has been widely criticized and debunked by experts, including Dr. Morgentaler. The study used a sick, older population and statistical manipulation to create a scare.

In reality, the legitimate science strongly indicates that low testosterone is a risk factor for cardiovascular disease, and optimizing it is protective. Testosterone benefits the cardiovascular system by:

• Improving Endothelial Health: It helps repair the delicate lining of our arteries.
• Promoting Arterial Dilation: It increases nitric oxide levels, thereby lowering blood pressure and improving blood flow.
• Enhancing Metabolic Function: It improves insulin sensitivity and helps manage blood sugar.
• Reducing Inflammation: It has powerful anti-inflammatory properties.
• Improving Body Composition: It helps build lean muscle and reduce dangerous visceral fat.

In my practice, cardiologists are one of my largest referral sources. They send me patients just months post-bypass surgery. We implement a comprehensive integrative plan to optimize hormone, vitamin, and inflammatory marker levels. Six months later, these patients returned to their cardiologist, having lost weight, normalized their blood pressure, and reversed their diabetes markers. The results speak for themselves.

The Role of Integrative Chiropractic Care in Hormonal Health

This journey to optimization is about a holistic, integrative approach. As a Doctor of Chiropractic, I always consider the foundational importance of the body’s structure. Chronic pain, spinal misalignments, and poor posture create a state of persistent physiological stress that disrupts the entire endocrine system.

• Reducing Neurological Interference: Spinal misalignments, or subluxations, can interfere with nerve function, disrupting the delicate feedback loops between the brain and hormone-producing glands. Chiropractic adjustments help to calm this sympathetic overdrive and improve the brain-body connection.
• Restoring Structural Integrity: Hormonal decline leads to joint pain and muscle weakness. Chiropractic care directly addresses the misalignments and muscle imbalances that are both causes and consequences of chronic pain. By restoring proper biomechanics, we reduce physical stress on the body.
• A Holistic Synergy: By integrating chiropractic care with functional medicine and hormone optimization, we address health on multiple levels. A chiropractic adjustment can relieve nerve pressure, while correcting hormonal imbalances reduces systemic inflammation and improves tissue repair. This creates a powerful, positive feedback loop in which structural improvements and physiological health build on each other, leading to lasting wellness that goes far beyond simply managing symptoms.

My clinical observations at PUSH-as-Rx confirm the success of this integrated model. We see patients finally break free from the cycle of pain, medication, and despair when we address both their hormonal and structural health simultaneously. It is the future of truly comprehensive and personalized patient care.

References

Chlebowski, R. T., Anderson, G. L., Aragaki, A. K., et al. (2020). Association of estrogen plus progestin with incidence of breast cancer and mortality after breast cancer diagnosis. JAMA, 324(4), 369–380.

Kim, Y. G., Kim, K., & Lee, Y. B. (2021). Association of serum testosterone levels with the risk of dementia in men: A retrospective cohort study. JAMA Neurology, 78(6), 731–738.

Manson, J. E., Chlebowski, R. T., Stefanick, M. L., et al. (2013). Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. JAMA, 310(13), 1353–1368.

Morgentaler, A., & Traish, A. M. (2009). Shifting the paradigm of testosterone and prostate cancer: The saturation model and the limits of androgen-dependent growth. European Urology, 55(2), 310-320.

Amor, R. C., MacLaughlin, K. D., Al-Azzawi, F., & Jones, H. (2005). The effect of testosterone pellets on bone mineral density in women. Obstetrics & Gynecology, 105(4), 86S.